EndoCare: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EndoCare
Largest movements
- Cash -€66,045
down €66,045 (-27.3%), from €242,210 to €176,165
mainly Contributions, distributions and other (-€170,000) and Current investments (-€42,823)
- Current investments +€42,823
new in 2025: €42,823
- Tangible fixed assets -€7,401
down €7,401 (-31.6%), from €23,394 to €15,993
of which Plant, machinery and equipment: -€5,006
- Receivables within one year +€5,554
new in 2025: €5,554
- Deferred charges and accrued income +€4,798
up €4,798 (+26.3%), from €18,230 to €23,028
- Other debts +€68,962
up €68,962 (+91.3%), from €75,538 to €144,500
- Profit (loss) carried forward -€58,736
down €58,736 (-42.2%), from €139,224 to €80,488
- Tax, wage and social debts -€30,315
down €30,315 (-50.0%), from €60,618 to €30,303
of which Taxes: -€29,909
- Gross operating margin +€34,284
up €34,284 (+23.3%), from €146,919 to €181,202
- Taxes +€7,363
up €7,363 (+29.9%), from €24,640 to €32,004
- Financial income -€6,420
down €6,420 (-58.0%), from €11,063 to €4,642
of which Non-recurring financial income: -€11,063
- Staff costs -€3,359
down €3,359 (-9.3%), from €36,195 to €32,836
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €283,834 | €263,564 | -€20,271 | -7.1% |
| Fixed assets | 21/28 | €23,394 | €15,993 | -€7,401 | -31.6% |
| Tangible fixed assets | 22/27 | €23,394 | €15,993 | -€7,401 | -31.6% |
| Plant, machinery and equipment | 23 | €20,999 | €15,993 | -€5,006 | -23.8% |
| Furniture and vehicles | 24 | €2,395 | - | -€2,395 | |
| Current assets | 29/58 | €260,440 | €247,571 | -€12,869 | -4.9% |
| Amounts receivable within one year | 40/41 | - | €5,554 | +€5,554 | |
| Other amounts receivable | 41 | - | €5,554 | +€5,554 | |
| Current investments | 50/53 | - | €42,823 | +€42,823 | |
| Cash at bank and in hand | 54/58 | €242,210 | €176,165 | -€66,045 | -27.3% |
| Deferred charges and accrued income | 490/1 | €18,230 | €23,028 | +€4,798 | +26.3% |
| Total equity and liabilities | 10/49 | €283,834 | €263,564 | -€20,271 | -7.1% |
| Equity | 10/15 | €142,524 | €83,788 | -€58,736 | -41.2% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Capital | 10 | €3,000 | €3,000 | = | 0.0% |
| Issued capital | 100 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €300 | €300 | = | 0.0% |
| Non-distributable reserves | 130/1 | €300 | €300 | = | 0.0% |
| Legal reserve | 130 | €300 | €300 | = | 0.0% |
| Profit (loss) carried forward | 14 | €139,224 | €80,488 | -€58,736 | -42.2% |
| Provisions and deferred taxes | 16 | €2,798 | €3,331 | +€533 | +19.1% |
| Provisions for liabilities and charges | 160/5 | €2,798 | €3,331 | +€533 | +19.1% |
| Other liabilities and charges | 164/5 | €2,798 | €3,331 | +€533 | +19.1% |
| Amounts payable | 17/49 | €138,513 | €176,445 | +€37,932 | +27.4% |
| Amounts payable within one year | 42/48 | €138,513 | €176,445 | +€37,932 | +27.4% |
| Trade debts | 44 | €2,357 | €1,642 | -€715 | -30.3% |
| Suppliers | 440/4 | €2,357 | €1,642 | -€715 | -30.3% |
| Taxes, remuneration and social security | 45 | €60,618 | €30,303 | -€30,315 | -50.0% |
| Taxes | 450/3 | €58,109 | €28,200 | -€29,909 | -51.5% |
| Remuneration and social security | 454/9 | €2,508 | €2,103 | -€406 | -16.2% |
| Other amounts payable | 47/48 | €75,538 | €144,500 | +€68,962 | +91.3% |
| Remuneration, social security and pensions | 62 | €36,195 | €32,836 | -€3,359 | -9.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,095 | €7,401 | +€1,307 | +21.4% |
| Other operating charges | 640/8 | €968 | €988 | +€20 | +2.0% |
| Gross operating margin | 9900 | €146,919 | €181,202 | +€34,284 | +23.3% |
| Operating profit (loss) | 9901 | €103,660 | €139,977 | +€36,316 | +35.0% |
| Financial income | 75/76B | €11,063 | €4,642 | -€6,420 | -58.0% |
| Recurring financial income | 75 | €11,063 | €4,642 | -€6,420 | -58.0% |
| Non-recurring financial income | 76B | €11,063 | - | -€11,063 | |
| Financial charges | 65/66B | €621 | €1,351 | +€730 | +117% |
| Recurring financial charges | 65 | €621 | €1,351 | +€730 | +117% |
| Profit (loss) for the period before taxes | 9903 | €114,102 | €143,268 | +€29,166 | +25.6% |
| Income taxes | 67/77 | €24,640 | €32,004 | +€7,363 | +29.9% |
| Profit (loss) for the period | 9904 | €89,461 | €111,264 | +€21,803 | +24.4% |
| Profit (loss) for the period to be appropriated | 9905 | €89,461 | €111,264 | +€21,803 | +24.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.